Neuroendocrine tumors, version 1.2015.


Journal Article

Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical Practice Guidelines in Oncology for Neuroendocrine Tumors discuss the diagnosis and management of both sporadic and hereditary NETs. This selection from the guidelines focuses on sporadic NETs of the pancreas, gastrointestinal tract, lung, and thymus.

Full Text

Cited Authors

  • Kulke, MH; Shah, MH; Benson, AB; Bergsland, E; Berlin, JD; Blaszkowsky, LS; Emerson, L; Engstrom, PF; Fanta, P; Giordano, T; Goldner, WS; Halfdanarson, TR; Heslin, MJ; Kandeel, F; Kunz, PL; Kuvshinoff, BW; Lieu, C; Moley, JF; Munene, G; Pillarisetty, VG; Saltz, L; Sosa, JA; Strosberg, JR; Vauthey, J-N; Wolfgang, C; Yao, JC; Burns, J; Freedman-Cass, D; National comprehensive cancer network,

Published Date

  • January 2015

Published In

Volume / Issue

  • 13 / 1

Start / End Page

  • 78 - 108

PubMed ID

  • 25583772

Pubmed Central ID

  • 25583772

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

International Standard Serial Number (ISSN)

  • 1540-1405

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2015.0011


  • eng